Gilman Sydney A. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2020
Insider Transaction Report
Form 4
Gilman Sydney A.
VP, Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2020-06-01+17,500→ 17,500 totalExercise: $4.64Exp: 2030-05-31→ Common Shares (17,500 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests in twelve nearly equal quarterly installments commencing on September 1, 2020.